News Release

 

Back
 

AmerisourceBergen Announces Investor Meeting and Webcast

11/08/02

VALLEY FORGE, Pa.--(BUSINESS WIRE)--Nov. 8, 2002-- AmerisourceBergen Corporation (NYSE:ABC) today announced that it plans to host an investor meeting in New York City on Thursday, December 5, 2002 and to broadcast the live proceedings via webcast.

The meeting and webcast will begin at 12:30 pm Eastern Standard Time and will end at approximately 2:30 pm.

Participating in the meeting and webcast will be R. David Yost, Chief Executive Officer, Kurt J. Hilzinger, President & Chief Operating Officer, Michael D. DiCandilo, Senior Vice President & Chief Financial Officer, as well as other members of the Company's management team. The meeting will focus on the Company's enhanced role in the Pharmaceutical Supply Channel.

The webcast will be accessible through AmerisourceBergen's web site, www.amerisourcebergen.com, and also through Street Events, www.streetevents.com. Users are encouraged to log on to the webcast approximately 15 minutes in advance of the scheduled start time of the call.

Following the live webcast, a replay will be made available on the AmerisourceBergen website three hours after the completion of the meeting and will remain available for approximately thirty days.

About AmerisourceBergen Corporation

AmerisourceBergen (NYSE:ABC) is the largest pharmaceutical services company in the United States dedicated solely to the pharmaceutical supply channel. It is the leading distributor of pharmaceutical products and services to the hospital systems/acute care market, alternative care providers, independent community pharmacies, and regional chains.

The company is also a leader in the institutional pharmacy marketplace. With over $40 billion in annualized operating revenues, AmerisourceBergen is headquartered in Valley Forge, PA, and employs more than 13,000 people serving over 25,000 customers.

Forward-Looking Statements

This press release may contain certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances.

Actual results may vary materially from the expectations contained in the forward-looking statements. Forward-looking statements may include statements addressing future financial and operating results of AmerisourceBergen and the benefits and aspects of the 2001 merger between AmeriSource Health Corporation and Bergen Brunswig Corporation.

The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: the risk that the businesses of AmeriSource and Bergen Brunswig will not be integrated successfully; failure to obtain and retain expected synergies; and other economic, business, competitive and/or regulatory factors affecting the business of AmerisourceBergen generally.

More detailed information about these factors is set forth in AmerisourceBergen's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for fiscal 2001, its Quarterly Reports on Form 10-Q for fiscal 2002, and the joint proxy statement-prospectus for the merger filed on August 1, 2001.

AmerisourceBergen is under no obligation to (and expressly disclaims any such obligation to) update or alter any forward-looking statements whether as a result of new information, future events or otherwise.

--30--NR/ph*

CONTACT: AmerisourceBergen Corporation, Valley Forge
Michael N. Kilpatric, 610/727-7118
mkilpatric@amerisource.com


Corporate Overview

AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel..

Learn More